Sriranganadane Dev

Title: Innovations of Sriranganadane Dev in Minor Histocompatibility Antigens

Introduction

Sriranganadane Dev is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of minor histocompatibility antigens (MiHAs). His work focuses on innovative methods for identifying novel MiHAs, which have important implications in medical research and treatment.

Latest Patents

Sriranganadane Dev holds 2 patents related to his groundbreaking work. His latest patents describe a novel method for human minor histocompatibility antigen (MiHA) discovery. This method includes the use of personalized translated transcriptome and/or exome in the database for peptide identification by mass spectroscopy (MS). Candidate MiHAs are identified by comparing the personalized transcriptome and/or exome to a reference genome and/or to the transcriptome and/or exome of an HLA-matched subject.

Career Highlights

Sriranganadane Dev is affiliated with the Université de Montréal, where he conducts his research. His innovative approaches have positioned him as a key figure in the study of minor histocompatibility antigens. His work is essential for advancing our understanding of immune responses and transplant compatibility.

Collaborations

Sriranganadane Dev collaborates with esteemed colleagues such as Claude Perreault and Pierre Thibault. These partnerships enhance the research and development of new methodologies in the field.

Conclusion

Sriranganadane Dev's contributions to the identification of minor histocompatibility antigens represent a significant advancement in medical research. His innovative methods and collaborations continue to influence the field positively.